Amica Retiree Medical Trust’s VeriSign VRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-407
Closed -$73K 216
2020
Q1
$73K Hold
407
0.07% 211
2019
Q4
$78K Hold
407
0.06% 280
2019
Q3
$77K Hold
407
0.06% 282
2019
Q2
$85K Hold
407
0.07% 276
2019
Q1
$74K Hold
407
0.07% 281
2018
Q4
$60K Hold
407
0.06% 286
2018
Q3
$65K Hold
407
0.05% 293
2018
Q2
$56K Hold
407
0.05% 311
2018
Q1
$48K Sell
407
-709
-64% -$82.1K 0.04% 325
2017
Q4
$128K Hold
1,116
0.1% 231
2017
Q3
$119K Hold
1,116
0.09% 246
2017
Q2
$104K Hold
1,116
0.08% 259
2017
Q1
$97K Hold
1,116
0.08% 265
2016
Q4
$85K Hold
1,116
0.07% 298
2016
Q3
$87K Hold
1,116
0.07% 273
2016
Q2
$96K Hold
1,116
0.08% 264
2016
Q1
$99K Hold
1,116
0.08% 252
2015
Q4
$97K Hold
1,116
0.08% 253
2015
Q3
$79K Hold
1,116
0.07% 272
2015
Q2
$69K Hold
1,116
0.06% 285
2015
Q1
$75K Hold
1,116
0.06% 283
2014
Q4
$64K Hold
1,116
0.05% 290
2014
Q3
$62K Hold
1,116
0.05% 290
2014
Q2
$54K Hold
1,116
0.04% 299
2014
Q1
$60K Hold
1,116
0.05% 280
2013
Q4
$67K Buy
+1,116
New +$61.4K 0.06% 265

Other funds holding VRSN

Amica Retiree Medical Trust's VRSN Position: Q2 2020 in Review

Amica Retiree Medical Trust sold out of VeriSign (VRSN) in Q2 2020, closing a stake of 407 shares — an estimated $73K sold.

Amica Retiree Medical Trust first reported a position in VRSN in Q4 2013 and held it in 26 quarters. The position peaked at $128K in Q4 2017. 558 funds tracked by Wall St. Rank hold VRSN as of Q2 2020.

  • Amica Retiree Medical Trust reported no remaining VeriSign position as of Q2 2020 after selling out during the quarter.
  • Amica Retiree Medical Trust sold 407 VeriSign shares in Q2 2020, an estimated $73K.
  • Amica Retiree Medical Trust first reported a position in VeriSign in Q4 2013 and held it in 26 quarters.
  • Amica Retiree Medical Trust's VeriSign position peaked at $128K in Q4 2017.
  • 558 funds tracked by Wall St. Rank held VeriSign as of Q2 2020.

Based on Amica Retiree Medical Trust's 13F filing for Q2 2020, filed 13 Aug 2020.